Medicare Enrolled
Dr. Sam Huang, M.D.
Hematology & Oncology · Orange, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Huang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Huang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Huang
Dr. Sam Huang is a hematology & oncology specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Huang performed 1,255 Medicare services across 532 unique beneficiaries.
Between the years covered by Open Payments, Dr. Huang received a total of $77,346 from 119 pharmaceutical and/or device companies across 1649 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Huang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 47% volume in CA
$77,346 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,255
Medicare services
Top 47% in CA for hematology & oncology
532
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~66 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
677 | $101 | $273 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
173 | $99 | $218 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
123 | $8 | $39 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
111 | $67 | $180 |
| New patient office visit, complex (60-74 min) | 46 | $161 | $405 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $66 | $185 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
40 | $8 | $27 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $145 | $466 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
19 | $10 | $32 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$77,346
Total received (2018-2024)
Avg $11,049/year across 7 years
Top 10% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
119
Companies
1,649
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$42,704 (55.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,470 (36.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,172 (8.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,922
2023
$8,865
2022
$11,990
2021
$5,222
2020
$16,031
2019
$9,181
2018
$14,135
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,749
Incyte Corporation
$3,443
BeiGene USA, Inc.
$754
Novartis Pharmaceuticals Corporation
$292
Celgene Corporation
$284
Takeda Pharmaceuticals U.S.A., Inc.
$249
Daiichi Sankyo Inc.
$233
Merck Sharp & Dohme LLC
$227
Alexion Pharmaceuticals, Inc.
$188
ABBVIE INC.
$185
GlaxoSmithKline, LLC.
$169
Janssen Biotech, Inc.
$157
PFIZER INC.
$145
Gilead Sciences, Inc.
$111
ARRAY BIOPHARMA INC
$104
Astellas Pharma US Inc
$100
Regeneron Healthcare Solutions, Inc.
$97
E.R. Squibb & Sons, L.L.C.
$93
Genentech USA, Inc.
$88
Becton, Dickinson and Company
$85
GENZYME CORPORATION
$84
PUMA BIOTECHNOLOGY, INC.
$83
SOBI, INC
$78
Lilly USA, LLC
$76
Exelixis Inc.
$74
Stemline Therapeutics Inc.
$73
Eisai Inc.
$67
Kite Pharma, Inc.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Karyopharm Therapeutics Inc.
$50
Aveo Pharmaceuticals, Inc.
$50
Sumitomo Pharma America, Inc.
$48
Immunocore Limited
$47
Bayer Healthcare Pharmaceuticals Inc.
$44
JAZZ PHARMACEUTICALS INC.
$41
Ipsen Biopharmaceuticals, Inc
$40
PharmaEssentia USA Corporation
$31
Legend Biotech USA Inc.
$28
Agios Pharmaceuticals, Inc.
$25
Deciphera Pharmaceuticals Inc.
$25
TAIHO ONCOLOGY, INC.
$21
Acrotech Biopharma Inc.
$20
SERVIER PHARMACEUTICALS LLC
$17
CSL Behring
$17
Genmab U.S., Inc.
$16
Top 3 companies account for 66.6% of 2024 payments
All-time payments by company (2018-2024) ›
Kite Pharma, Inc.
$14,300
AstraZeneca Pharmaceuticals LP
$12,725
Incyte Corporation
$4,725
Athenex Pharmaceutical Division, LLC
$4,025
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,510
Janssen Scientific Affairs, LLC
$2,713
Celgene Corporation
$2,481
Takeda Pharmaceuticals U.S.A., Inc.
$2,341
BeiGene USA, Inc.
$2,303
E.R. Squibb & Sons, L.L.C.
$1,559
PFIZER INC.
$1,447
Puma Biotechnology, Inc.
$1,409
GENZYME CORPORATION
$1,324
Daiichi Sankyo Inc.
$1,255
Novartis Pharmaceuticals Corporation
$1,149
Janssen Biotech, Inc.
$1,029
Merck Sharp & Dohme Corporation
$1,026
Amgen Inc.
$1,015
Pharmacyclics LLC, An AbbVie Company
$1,000
Astellas Pharma US Inc
$853
EMD Serono, Inc.
$829
Merck Sharp & Dohme LLC
$782
Genentech USA, Inc.
$659
Lilly USA, LLC
$646
GlaxoSmithKline, LLC.
$640
Eisai Inc.
$592
Bayer HealthCare Pharmaceuticals Inc.
$567
Exelixis Inc.
$565
Gilead Sciences, Inc.
$537
Seagen Inc.
$522
Alexion Pharmaceuticals, Inc.
$405
Covis Pharma GmBH
$400
Regeneron Healthcare Solutions, Inc.
$399
ABBVIE INC.
$350
Karyopharm Therapeutics Inc.
$321
ARRAY BIOPHARMA INC
$286
AVEO Pharmaceuticals, Inc.
$270
Ipsen Biopharmaceuticals, Inc
$263
COMSORT, Inc
$250
Blueprint Medicines Corporation
$205
Novocure GmbH
$200
EISAI INC.
$180
AbbVie Inc.
$168
Stemline Therapeutics Inc.
$163
Bayer Healthcare Pharmaceuticals Inc.
$161
MorphoSys, US Inc.
$154
TESARO, Inc.
$147
PUMA BIOTECHNOLOGY, INC.
$146
Pharmacyclics LLC, an AbbVie Company
$143
Seattle Genetics, Inc.
$135
Novocure Inc.
$135
AbbVie, Inc.
$135
NOVARTIS PHARMACEUTICALS CORPORATION
$132
AMAG Pharmaceuticals, Inc.
$127
Epizyme, Inc.,
$123
Agios Pharmaceuticals, Inc.
$118
SOBI, INC
$118
Coherus Biosciences Inc.
$110
Taiho Oncology, Inc.
$110
Clovis Oncology, Inc.
$103
Genmab U.S., Inc.
$100
Cardinal Health 110 LLC
$100
CSL Behring
$93
Verastem, Inc.
$93
Janssen Pharmaceuticals, Inc
$92
TerSera Therapeutics LLC
$90
Mylan Institutional Inc.
$89
Teva Pharmaceuticals USA, Inc.
$85
Becton, Dickinson and Company
$85
Myovant Sciences Inc.
$84
GE HealthCare
$77
Aveo Pharmaceuticals, Inc.
$76
TAIHO ONCOLOGY, INC.
$75
Sumitomo Pharma America, Inc.
$71
MEDIVATION FIELD SOLUTIONS LLC
$70
Foundation Medicine, Inc.
$69
Spectrum Pharmaceuticals Inc.
$66
PharmaEssentia USA Corporation
$64
Otsuka America Pharmaceutical, Inc.
$63
CTI BioPharma Corp.
$61
Octapharma USA, Inc.
$56
Deciphera Pharmaceuticals Inc.
$52
Dendreon Pharmaceuticals LLC
$50
Kyowa Kirin, Inc.
$48
Dova Pharmaceuticals
$47
Immunocore Limited
$47
INSYS Therapeutics Inc
$46
Sirtex Medical Inc
$46
EUSA Pharma (US) LLC
$43
Pharmacosmos Therapeutics Inc.
$42
JAZZ PHARMACEUTICALS INC.
$41
Lexicon Pharmaceuticals, Inc.
$40
R-Pharm US LLC
$38
SANOFI-AVENTIS U.S. LLC
$34
Mirati Therapeutics, Inc.
$34
Acrotech Biopharma Inc.
$33
Helsinn Therapeutics (U.S.), Inc.
$33
Sobi, Inc
$31
Aurobindo Pharma USA, Inc.
$31
Rigel Pharmaceuticals, Inc.
$28
Legend Biotech USA Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
ACCORD HEALTHCARE, INC.
$28
Shire North American Group Inc
$27
Acceleron Pharma, Inc.
$26
Myriad Genetic Laboratories, Inc.
$25
ADC Therapeutics America, Inc.
$24
Genentech, Inc.
$24
ImmunoGen, Inc.
$23
Jazz Pharmaceuticals Inc.
$23
Apellis Pharmaceuticals, Inc.
$22
Servier Pharmaceuticals LLC
$22
Immunomedics, Inc.
$21
Acrotech Biopharma LLC
$21
G1 Therapeutics, Inc.
$20
TG Therapeutics, Inc.
$19
Cumberland Pharmaceuticals, Inc.
$18
SERVIER PHARMACEUTICALS LLC
$17
RECORDATI_RARE_DISEASES_INC.
$17
Top 3 companies account for 41.0% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · Fulphila · GAMIFANT · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idelvion · Imbruvica · Ixempra · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYCHOICE CDX · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Oncology · Onivyde · Oral Paclitaxel · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RECOTHROM · RETACRIT · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUBSYS · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecartus · Tecentriq · Tepmetko · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vanflyta · Vectibix · Venclexta · Venovo · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for hematology & oncology in CA.
Geographic Context
Hematology & oncology specialists within 10 mi
243
Per 100K population
7.7
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Huang is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 10% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Huang experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Huang performed 677 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Huang receive payments from pharmaceutical companies?
Yes. Dr. Huang received a total of $77,346 from 119 companies across 1,649 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Huang's costs compare to other hematology & oncology specialists in Orange?
Dr. Huang's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Huang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Orange
Browse hematology & oncology specialists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology